Delivery Order SPE2DB20D1109-SPE2DB25FN96X

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB25D3404|SPE2DB25FUNDP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,773.54 delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. This award is not associated with a set-aside program and is open to full...
This federal contract award, with ID SPE2DB22D1052|SPE2DB25FU9AH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,807.25 firm fixed-price delivery order is for the supply of the medication CAPLYTA 21 MG CAPSULE 30S. This contract is not designated as a set-aside and has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken,...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FZ6V1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $4,991.80 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any specific business category....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.26 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.73 Firm Fixed Price delivery order contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,171.22, is a delivery order for the provision of CAPLYTA 21 MG CAPSULE 30S. The contract is a firm fixed-price agreement with an ultimate completion date of April 14, 2025. This contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,407.39 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of March 18, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $11,865.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,110.70 firm-fixed-price delivery order covers the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, through December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ46T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,369.00 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN96X
    Delivery Order

This federal contract award, identified as SPE2DB20D1109|SPE2DB25FN96X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,458.53 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a prescription medication. This award is not associated with a set-aside program.

The contract has an ultimate completion date of April 29, 2025 and was awarded on April 28, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization headquartered in Conshohocken, Pennsylvania. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:17 AM